超滤膜联合高级氧化技术深度处理综合工业污水的研究

采用超滤膜联合高级氧化技术对混合工业园区污水中难降解有机污染物、色度、总大肠菌等进行深度处理。结果表明:运行8周后悬浮物、COD、氨氮、总磷和色度的平均去除率分别为92%、90%、70%,63%和90%,总大肠菌去除率达100%。最终出水水质均可达到城市回用水水质标准。     

一体式膜生物反应器处理屠宰废水

用一体式膜生物反应器经过90d的连续运行对屠宰废水的处理进行研究。试验结果表明,出水CODCr和BOD5稳定,平均去除率均达95%以上;NH3-N的去除率高达93.7%;对TSS、浊度、SS及动物油脂的去除率分别>99.0%、99.3%和95.8%,在工艺运行的90d里未发生膜污染现象。     

聚合氯化铁铝应用于城市污水一级处理试验研究

以济南市水质净化一厂初沉池进水为试验水样,在设定的反应条件下,以浊度、COD、TP、TN、NH3-N等为测定指标,做了大量的烧杯搅拌试验,综合分析了聚合氯化铁铝(PFAC)的处理效果。试验结果显示其最佳投药量为25mg/L左右,去除率浊度在90%以上、COD70%～90%、TP70%～95%左右、TN、NH3-N分别在30%和15%左右。     

中国典型城市机动车排放演变趋势

选择中国12个典型城市建立1990~2009年机动车排放清单,分析各城市机动车排放历史演变趋势.结果显示,1990~2009年,研究各城市CO、VOCs、NOx和PM排放因子分别降低57%~81%、53%~78%、22%~74%和31%~76%.20年间,各城市CO和VOCs排放量总体在2000年后陆续达到增长峰值后开始下降,总量分别增长1.0倍和1.4倍;NOx和PM排放量总体保持持续增长,分别增长3.2倍和3.3倍.各城市汽油车是CO和VOCs排放主要贡献源,LDA-G、MDTB-G和HDTB-G对各城市机动车CO和VOCs排放的贡献和分别为约70%~90%和约50%~85%,其中LDA-G的排放贡献明显提高.LDA-G、MDTB-G、MDTB-D和HDTB-D贡献了80%~90%的NOx排放,其中MDTB-D和HDTB-D的排放贡献率从平均57.8%上升为72.7%.对于PM,MDTB-D和HDTB-D占排放的70%~90%.此外,部分城市摩托车排放的贡献不容忽视.     

MBBR工艺处理制革废水中试研究

针对某皮革废水NH3-N高的特点,采用预处理去除80%的SS、90%的S2-、80%的铬及60%的CODCr后,废水采用A＋O＋MBBR工艺,改造后工艺达到了CODCr去除效率90%,NH3-N去除效率98%,实现了制革废水的达标。     

富营养污水简易集成治理方法研究

以粉煤灰制成空心多功能污水处理材料,用该污水处理材料填充成五级絮凝降解过滤箱,在曝气协同下组成集吸附絮凝过滤与化学降解于一体的富营养水处理系统.在富营养水流量、曝气量分别为60L/h、40L/m3·h的工艺条件下,富营养水的可溶性盐、色度、CODcr、BOD5、氨氮、总磷等主要污染物指标分别降低93%、90%、95%、90%、86%和92%.该富营养水处理系统具有处理效果好、工艺简单和结构紧凑的特点.     

黄河源区气候和土地覆被变化对径流的影响

采用2个分布式水文模型(SWAT和VIC)分析了1960～2000年黄河源区气候变化和土地覆被对径流的影响.分析表明,气候变化是径流减少的主要原因,20世纪90年代以前,土地覆被变化对径流影响很小,气候变化对径流的影响在95%以上.70～90年代,气候变化的水文效应大约为65%～80%;土地利用变化的影响大致为6%～16%;生态退化,冻土融化等的水文效应大约为14%～20%.20世纪90年代气候变化主要体现在黄河源区降水的时空分布发生改变和气温的升高上.     

李氏禾净化含重金属生活污水的实验

采用水培方法设置了CK(0%)、40%、50%、60%、70%、80%、90%和100%等8个生活污水浓度比例梯度,在相同李氏禾(Leersia hexandra Swartz)株数的基础上,分别投加Cr6+、Cu2+和Ni2+等金属离子,研究铬超富集植物李氏禾对重金属、有机污染物(COD)、氨氮及总磷去除效果。结果表明,李氏禾对废水中Cr6+、Cu2+和Ni2+的去除能力很强,氨氮和总磷的去除效率分别可达到98%和90%以上,对COD降解可达80%以上。李氏禾对3种重金属的吸收结果表明,复合污染废水中生活污水含量越高,越有利于李氏禾对Cr6+和Ni2+的净化,而不利于对Cu2+的净化。     

稻草覆盖对赣南稀土尾渣坡面产流产沙的影响

生物覆盖措施能显著降低敏感脆弱带及裸露坡地水土流失,且具有成本低、见效快等特点,适合在矿区推广.为研究稻草覆盖对稀土尾渣坡面水土流失过程的影响,采用人工模拟降雨试验,对比研究不同雨强（60和90 mm/h）和不同稻草覆盖度（0%、50%和100%）条件下稀土尾矿地表产流、产沙情况.模拟降雨试验在位于江西省九江市德安县的江西省水土保持生态科技园开展,不同雨强采用西安清远测控技术有限公司设计的QYJY-503人工模拟降雨系统进行控制.结果表明:雨强为60 mm/h时,50%和100%稻草覆盖度处理坡面径流开始时间分别比0%稻草覆盖度坡面延迟46%和91%;雨强为90 mm/h时,延迟幅度分别为3.0和4.8倍.0%、50%和100%稻草覆盖度条件下稀土矿渣坡面单位时间产流量分别在产流开始后6、31和41 min达到稳定值.60 mm/h雨强条件下稀土矿渣坡面1 h总产流量呈现0%稻草覆盖度> 100%稻草覆盖度> 50%稻草覆盖度（P < 0.05）,而90 mm/h雨强条件下则为0%稻草覆盖度> 50%稻草覆盖度> 100%稻草覆盖度（P < 0.01）.雨强为60 mm/h时,50%和100%稻草覆盖度稀土矿渣坡面土壤侵蚀量分别比0%稻草覆盖度坡面降低73.46%和84.53%;而雨强为90 mm/h时,2种措施土壤侵蚀量降幅分别为54.83%和72.14%.研究显示,稻草覆盖措施可以有效降低矿区土壤坡面径流、泥沙产量.      

序批式曝气生物滤池处理生活污水的中试研究

报道了沸石为填料的序批式曝气生物滤池处理生活污水的中试实验,研究了曝气时间、曝气量和生活污水浓度对处理效果的影响。结果表明,沸石作曝气生物滤池的填料效果较好。曝气2h后,即可达到很好的去除效果,污水进水COD和BOD5浓度分别为300～800mg/L和170～400mg/L时,去除率分别达到90%～70%和90%～88%。进水COD浓度分别为312.6mg/L和530.6mg/L,曝气量0.6m3/h,处理2h后出水COD浓度分别为30.63mg/L和103.92mg/L,去除率>90%,出水达到污水处理二级排放标准。因此,以沸石为填料的序批式曝气生物滤池是一种高效、低耗、具有较好应用前景的单体生活污水处理设备。     

Transabdominal villus sampling in early second trimester: A safe sampling method for women of advanced age

Transabdominal chorionic villus sampling (TA-CVS) was performed in 707 viable singleton pregnancies to exclude chromosomal abnormalities. Maternal age ranged between 36 and 49 years (mean 37·9 years); gestational age varied between 10·2 and 18·3 weeks (mean 13·3 weeks). In 639 women (90·4 per cent), a sufficient amount of chorionic tissue (⩾ 10 mg) was obtained after one needle insertion; in 66 women (9·3 per cent) two insertions were needed. An abnormal chromosome pattern was established in 19 cases (2·9 per cent). Vaginal bleeding or spotting within 28 days after TA-CVS occurred in 11 cases (1·5 per cent). The completed follow-up of 678 chromosomally normal pregnancies showed an overall fetal loss rate of 2·6 per cent before 28 weeks. The overall perinatal mortality was 0·9 per cent. When relating fetal loss to gestational age at TA-CVS, this was 6·6 per cent in women sampled before 12 weeks against only 1·8 per cent after 12 weeks. At the same time, the percentage of fetal loss occurring within 2 weeks following the procedure was 75 and 30 per cent, respectively. It is suggested that these data reflect the decline in spontaneous abortion rate during this particular period of pregnancy. It is concluded that TA-CVS is an effective procedure which, when performed after the natural decrease of fetal loss, appears to be a safe option for women of advanced maternal age.     

Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the collaborative acetylcholinesterase study

Seventeen centres from Australia, Britain, France, and the United States collaborated in a study to compare amniotic fluid acetylcholinesterase (AChE) determination by gel electrophoresis and amniotic fluid alpha-fetoprotein (AFP) measurement as diagnostic tests for open neural tube defects. The study was based on 32 642 women with singleton pregnancies (including 428 with open spina bifida and 238 with anencephaly) who had an amniocentesis at 13–24 weeks' gestation. The AChE test yielded a detection rate for open spina bifida of 99 per cent (95 per cent confidence interval 98–100 per cent), 98 per cent for anencephaly (95 per cent confidence interval 96–100 per cent), and a false-positive rate of 0.34 per cent (95 per cent confidence interval 0.28–0.40 per cent) excluding miscarriages, intrauterine death, and serious fetal abnormalities. The false-positive rate was 0.30 per cent among the 13 centres that used a specific AChE inhibitor in the test. Comparable rates for the AFP test were less favourable. (For example, the open spina bifida detection rate was 90 per cent and the false-positive rate was 0.46 per cent using the cut-off levels specified in the U.K. Collaborative AFP Study.) The AChE false-positive rate was lower in samples that were not bloodstained (0.16 per cent) than in those that were (2.4 per cent). It was higher in women who had an amniocentesis on account of a raised maternal serum AFP level (0.56 per cent) than in those who had one for other reasons (0.29 per cent). The best results were obtained by a combination of the two tests, an effective and economical policy being to perform the AFP measurement on all amniotic fluid samples and an AChE test on samples with AFP levels greater than or equal to 2.0 multiples of the normal median (about 5 per cent of all samples). Using this policy, the open spina bifida detection rate was 96 per cent and the false-positive rate was 0.14 per cent (0.06 per cent for samples that were not bloodstained and 1.2 per cent for those that were; 0.40 per cent for women with raised serum AFP levels and 0.09 per cent for other women). This policy offers a useful improvement to the prenatal diagnosis of open spina bifida.     

A simple,rapid, and highly informative PCR-based procedure for prenatal diagnosis and carrier screening of phenylketonuria

The polymorphic information content (PIC) and the degree of heterozygosity of several polymorphic systems within the phenylalanine hydroxylase (PAH) gene were determined in 85 European Caucasian and 19 Chinese phenylketonuria (PKU) kindreds. The first system examined, a short tandem repeat (STR), had a PIC of 80 and 73 per cent in these Caucasian and Chinese samples, respectively. The degree of heterozygosity actually observed for this system was 81 and 64 per cent in the Caucasian and Chinese PKU families, respectively. Through the addition of a second polymorphism based on a variable number of tandem repeats (VNTR), the PIC was increased to 90 per cent in Caucasians, but only to 75 per cent in Chinese. The degree of heterozygosity observed for this combination was 94 per cent in European PKU families and 67 per cent in Chinese PKU families. The further addition of an Xmnl RFLP increased both the PIC and the level of heterozygosity in Caucasians to 95 per cent, but did not change either of these measures in Chinese. The combined use of these three polymorphisms significantly increases the informativity of prenatal diagnostic and carrier screening procedures in both Caucasian and Chinese PKU kindreds. Furthermore, since each of these polymorphisms can be studied by PCR-based methods, these new tests can be performed more quickly and easily than previous Southern-based procedures.     

Cytogenetic analysis of 2928 CVS samples and 1075 amniocenteses from randomized studies

We report cytogenetic results from a randomized Danish chorionic villus sampling (CVS) and amniocentesis (AC) study including 2928 placental and 1075 amniotic fluid specimens processed in the same laboratory. The results are presented in groups comparing CVS with amniocentesis and transabdominal (TA) CVS with transcervical (TC) CVS as randomized. More abnormalities and more ambiguous diagnostic problems were found in placental tissues than in amniotic cells. There were no diagnostic errors and no incorrect sex predictions. Mosaicism was detected in 1 per cent of all cases of CVS (discordancies included). When confirmation studies were done, 90 per cent were found to be confined to the placenta. Eight cases (0.7 per cent) of mosaicism/pseudomosaicism were seen in amniotic fluid specimens, and two cases of five with confirmation studies were confirmed in the fetus. The rate of mosaicism/pseudomosaicism in CVS and AC specimens differed (P <0.05). The rate of pseudomosaicism in cultures of villi and amniotic fluid cells was 0.5 and 0.6 per cent, respectively. Single-cell aneuploidy was observed in 1.8 per cent of villi and 1.4 per cent of amniotic fluid cell specimens. Maternal cell contamination (MCC) was seen more often after TC sampling (4.5 per cent) compared with TA sampling (1.5 per cent), but posed no problems in interpretation. Compared with the processing of cultured specimens, the short-term method of preparation of villi in our laboratory doubled the technicians' workload. For practical and economic reasons we have ceased the routine use of short-term preparations.     

Co-amplification of the cystic fibrosis ΔF508 mutation with the HLA DQA1 sequence in single cell PCR: Implications for improved assessment of polar bodies and blastomeres in preimplantation diagnosis

We have developed a heminested PCR (polymerase chain reaction) method, performed on single cells, for the analysis of the most common cystic fibrosis (CF) mutation (AF508). As a quality control, the polymorphic exon 2 of the HLA DQA1 locus was co-amplified from the same cell. With a non-radioactive reverse dot-blot assay, the genotype of these two loci could be determined. Experiments on 98 single fibroblasts, heterozygous for the CFTR and the DQA1 locus, showed that amplification of either locus could be obtained in 97 per cent of the cases, but only 90 per cent showed heterozygosity for CF, 75 per cent showed heterozygosity for DQA1, and 74 per cent showed heterozygosity for both CF and DQA1. Contaminations detected only after DQA1 typing occurred in 3 per cent of our samples. Error rate calculations based on our experimental PCR data indicate that single blastomere diagnosis would lead to unacceptable errors, i.e., an affected fetus, in less than 1 per cent of the cases. The risk of undetected crossing-over or the dubious results that crossing-over could generate, would make isolated polar body diagnosis at the present time very difficult. The combined approach of PCR on polar bodies followed by confirmation of the diagnosis on blastomeres, however, should give a solid base for preimplantation diagnosis of monogenic disorders.     

Short communication kazal type trypsin inhibitor in amniotic fluid in fetal developmental disorders

The amniotic fluid concentrations of the Kazal type trypsin inhibitor were studied in pregnancies with fetal developmental disorders. The samples were obtained by amniocentesis between 14 and 19 weeks of gestation. In cases with fetal malformations, the level was below the normal 10th centile in 15 out of 28 cases (54 per cent, P<0.05) and above the normal 90th centile in 2 cases (7.1 per cent). Low values were common in cases with intrauterine fetal death or congenital nephrosis. The levels were normal in fetal chromosomal aberrations.     

A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects

Amniotic fluid samples received for routine prenatal diagnosis of open neural tube defects were used for a study to compare amniotic fluid acetylcholinesterase (AChE) determination using a monoclonal antibody (4F19) enzyme antigen immunoassay and amniotic fluid alpha-fetoprotein (AFP) measurement as diagnostic tests for open neural tube defects. The study was based on 9964 women with singleton pregnancies and known outcome (including 6 with anencephaly and 18 with open spina bifida) having an amniocentesis at 14–23 weeks of gestation. The AChE immunoassay yielded detection rates for anencephaly of 100 per cent (95 per cent confidence interval (CI) 54·07–100 per cent), for open spina bifida of 100 per cent (95 per cent CI 81·47–100 per cent), for anterior abdominal wall defects of 20 per cent (95 per cent CI 0-51-71-64 per cent), and a false-positive rate of 0·22 percent (95 per cent CI 0·14–0·34 per cent) excluding anencephaly, open spina bifida, and anterior abdominal wall defects. For similar detection rates the false-positive rate of the AFP test was significantly higher, 0·74 per cent (95 per cent CI 0·58–0·94 per cent). On the basis of these findings, it is recommended that the technically simple AChE immunoassay should be used on all samples; the AFP test should only be used on the 0·5 per cent of the samples with concentrations of AChE activity ⩾ 8·5 nkat/1 for clear samples and blood-stained samples becoming clear after centrifugation, and ⩾ 25·0 nkat/1 for blood-stained samples that are discoloured after centrifugation; an AFP cut-off level of 2·0 MOM is recommended for this policy. Thereby, the detection rates for anencephaly, open spina bifida, and anterior abdominal wall defects would be 100, 100, and 20 per cent, respectively (95 per cent CIs 54·07–100, 81·47–100, and 0·51–71·64 per cent, respectively), and the false-positive rate would be 0·08 per cent (95 per cent CI 0·03–0·16 per cent) (excluding anencephaly, open spina bifida, and anterior abdominal wall defects).     

Cystic Adenomatoid malformation of the lung: Prenatal diagnosis and outcome

During an 8-year period (1984–1992), we made the ultrasonographic diagnosis of cystic adenomatoid malformation (CAM) of the lung in 58 fetuses at 17–39 weeks' gestation. We reviewed the records of these fetuses and combined the data from 74 cases reported in the literature to determine the incidence of the different types of CAM, associated malformations, and outcome. The lesions were macrocystic in 78 (59 per cent) and microcystic in 54 (41 per cent) of the cases. CAM was left-sided in 51 per cent, right-sided in 35 per cent, and bilateral in 14 per cent of the fetuses. In 15 (11 per cent) of the fetuses there were additional malformations and 57 (43 per cent) were hydropic. The pregnancy was electively terminated in 44 (33 per cent) of the cases, including all those with bilateral CAM. There were six (5 per cent) intrauterine deaths, five in association with hydrops, and one with growth retardation and heart defect. Of the 82 (62 per cent) infants that were liveborn, 21 (26 per cent) died in the neonatal period, 15 before and six after surgery. Of the 61 survivors, 16 (26 per cent) did not require surgery. In the 88 cases where the pregnancy was not terminated, survival was better if the CAM was macrocystic (74 per cent versus 58 per cent for microcystic), if there was no hydrops (92 per cent versus 21 per cent for hydrops), and if the amniotic fluid volume was normal or decreased (82 per cent versus 53 per cent for polyhydramnios).     

The prognostic factors in the prenatal diagnosis of the echogenic fetal lung

The prenatal diagnosis of an echogenic fetal lung (EFL) is now often made in the early second trimester using high-resolution ultrasound. This ultrasound appearance is usually caused by a congenital cystic adenomatoid lung malformation (CCAM), an intrapulmonary lung sequestration or obstruction of a major airway. In order to provide prognostic guidelines to parents who may be considering termination of a fetus with these findings, we have analysed a series of 11 cases diagnosed in our centre over the past 2 years in conjunction with 60 cases from major published series. The data suggest that in the absence of non-immune hydrops fetalis (NIHF) or other anomalies, the outcome for the fetuses is excellent, with over 90 per cent survival. Neither early diagnosis (24 weeks) nor the presence of mediastinal shift is a poor prognostic indicator. In addition, it appears that if NIHF is absent at diagnosis, the chance that it will develop as the pregnancy continues is small (6 per cent). Furthermore, there is a significant (up to 30 per cent) chance that this ultrasound finding will resolve in utero. The development of in utero fetal surgical techniques may be the only hope for those hydropic fetuses who appear to have a dismal prognosis.     

The effect of oxygen tension on colony formation and cell proliferation of amniotic fluid cellsin vitro

The effects of reduced oxygen concentrations in the gas phase over the culture medium on colony formation and cell proliferation were investigated in high and low cell density primary and secondary cultures of amniotic fluid cells. Using two standard culture methods (25 cm² plastic flasks and Leighton type tubes) a significantly reduced culture time was observed at high cell density for mass cultures by incubation within a low oxygen tension gas phase (2.5 per cent to 7.5 per cent O₂) instead of conventional air (18 per cent O₂). At low cell density colony formation was significantly enhanced in cultures grown at reduced oxygen tension. Using gas permeable membranes as support, lowering the oxygen tension from 7.5 per cent to 2.5 per cent yielded an increase in plating efficiency of cells from approximately 5 per cent to 25 per cent, whereas plating efficiency was less than 2 per cent for cells grown at ambient 18 per cent O₂. It is suggested that low oxygen tension in the gas phase is an effective means of enhancing clonal growth in amniotic fluid cell cultures, thereby reducing both culture time and risk of culture failure.